ALGIERS, Algeria, November 2, 2011 /PRNewswire/ -- National agreement result of intensive cooperation on defining research

RESEARCH TRIANGLE PARK, N.C., May 4 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer. Mr.

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that Richard J. Whitley, MD has been appointed to the company's Board of Directors, bringing the number of Directors to 11. Dr.

Research and Markets (http://www.researchandmarkets.com/reports/c46005) has announced the addition of Antiviral Drugs to their offering. Viruses are microorganisms that are as varied in type as the plants and animals of the macroscopic world.